Test Update // Global MAPS® (CSF)

Dear Valued Clients, 

Thank you for your continued trust in Baylor Genetics as your genetic testing partner. As we continue to upgrade and refine our test menu and services, we want you to be the first to know about changes that may affect your testing experience with us. 

Effective immediately, cerebrospinal fluid (CSF) will no longer be an accepted sample type for Global Metabolomic Assisted Pathway Screen (Global MAPS®, test code 4902). Instead of CSF, we recommend submitting a blood sample (test code 4900).  

For additional information on BG’s test offerings and requisitions, please visit https://test-dev.baylorgenetics.com. 

If you have specific questions regarding this update, please contact your Baylor Genetics account representative, call our Client Relations Division at 1-800-411-4363, or email us at help@baylorgenetics.com 

Thank you for your continued business. 

Previous Post
Test Update // Whole Genome Sequencing
Next Post
Test Launch // Rapid Whole Genome Sequencing